Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00331760 · OUTCOME

Percentage of Cervical Carcinoma Patients That Were Chemotherapy Compliant

Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery · Source last updated 2019-02-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
From start to end of chemotherapy, approximately five weeks from registration.

What was measured

Chemotherapy treatment was centrally reviewed for quality assurance and compliance once complete chemotherapy treatment data was received from sites.

Analysis population: Eligible patients in the chemotherapy group (cervical cancer patients) who started study treatment

Groups in this outcome

Cervical Cancer: IMRT + Chemotherapy (Cisplatin)

Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cervical Cancer: IMRT + Chemotherapy (Cisplatin)40

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Cervical Cancer: IMRT + Chemotherapy (Cisplatin)80Not reported6590Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        65
        upper Limit
        90
        value
        80
denoms
  1. counts
    1. group Id
      OG000
      value
      40
    units
    Participants
description
Chemotherapy treatment was centrally reviewed for quality assurance and compliance once complete chemotherapy treatment data was received from sites.
dispersion Type
95% Confidence Interval
groups
  1. description
    Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)
    id
    OG000
    title
    Cervical Cancer: IMRT + Chemotherapy (Cisplatin)
param Type
NUMBER
population Description
Eligible patients in the chemotherapy group (cervical cancer patients) who started study treatment
reporting Status
POSTED
time Frame
From start to end of chemotherapy, approximately five weeks from registration.
title
Percentage of Cervical Carcinoma Patients That Were Chemotherapy Compliant
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice